XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 69.1 $ 21.8
Restricted cash 35.1 31.6
Accounts receivable 611.6 536.8
Prepaid expenses 34.5 34.9
Other current assets 91.5 92.1
Total current assets 841.8 717.2
Property and equipment, net 3,301.0 2,939.2
Operating lease right-of-use assets 208.5 212.5
Goodwill 1,281.3 1,263.2
Intangible assets, net 278.2 282.3
Other long-term assets 191.6 222.1
Total assets [1] 6,102.4 5,636.5
Current liabilities:    
Current portion of long-term debt 24.8 25.2
Current operating lease liabilities 24.1 25.6
Accounts payable 170.0 132.9
Accrued payroll 207.5 168.3
Accrued interest payable 42.6 42.8
Other current liabilities 187.4 181.1
Total current liabilities 656.4 575.9
Long-term debt, net of current portion 2,687.8 2,741.8
Long-term operating lease liabilities 196.1 199.7
Self-insured risks 131.8 128.5
Deferred income tax liabilities 87.0 83.0
Other long-term liabilities 46.1 45.7
Total liabilities [1] 3,805.2 3,774.6
Commitments and contingencies
Redeemable noncontrolling interests 42.0 35.6
Encompass Health shareholders’ equity:    
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 115,416,676 in 2023; 114,775,056 in 2022 1.2 1.1
Capital in excess of par value 1,787.0 1,730.2
Accumulated income 406.5 115.7
Treasury stock, at cost (15,163,909 shares in 2023 and 14,992,125 shares in 2022) (547.2) (536.7)
Total Encompass Health shareholders’ equity 1,647.5 1,310.3
Noncontrolling interests 607.7 516.0
Total shareholders’ equity 2,255.2 1,826.3
Liabilities and Equity, Total [1] $ 6,102.4 $ 5,636.5
[1] Our consolidated assets as of December 31, 2023 and December 31, 2022 include total assets of variable interest entities of $207.7 million and $207.8 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2023 and December 31, 2022 include total liabilities of the variable interest entities of $42.2 million and $47.9 million, respectively. See Note 4, Variable Interest Entities.